Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rTMS and Synaptic Plasticity in MDD
NCT04311619Phase 1Withdrawn
- Start
- Dec 2019
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial. Primary endpoint: Change in Synaptic Density Quantified by Regional Binding Potential (BP_ND). Planned start Dec 2019; status: withdrawn.
Beyond the preview
Go deeper on NCT04311619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04311619.